Kindly MD, Inc. (NAKA)

Kindly MD Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	2.24	2.72	3.77
Revenue Growth (YoY)	-27.67%	-27.83%	-
Cost of Revenue	0.03	0.08	0.23
Gross Profit	2.21	2.64	3.54
Selling, General & Admin	7.6	5.47	5.05
Depreciation & Amortization Expenses	0.12	0.14	0.11
Research & Development	-	0.38	0
Total Operating Expenses	7.72	5.98	5.16
Operating Income	-5.51	-3.35	-1.62
Interest Expense	-0.03	-0.39	-0.06
Other Non-Operating Income (Expense)	0.11	0.2	0.06
Total Non-Operating Income (Expense)	0.08	-0.19	0
Pretax Income	-5.47	-3.62	-1.62
Net Income	-5.47	-3.62	-1.62
Net Income to Common	-5.47	-3.62	-1.62
EBIT	-5.51	-3.35	-1.62

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q